By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Acusphere, Inc.

Acusphere, Inc. (ACUS)

OTC Currency in USD
$0.03
+$0.02
+249.90K%
Last Update: 29 Aug 2025, 00:00
$123.78K
Market Cap
0.00
P/E Ratio (TTM)
Forward Dividend Yield
$0.00 - $0.03
52 Week Range

ACUS Stock Price Chart

Explore Acusphere, Inc. interactive price chart. Choose custom timeframes to analyze ACUS price movements and trends.

ACUS Company Profile

Discover essential business fundamentals and corporate details for Acusphere, Inc. (ACUS) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

8 Oct 2003

Employees

CEO

William I. Ramage D.Phil

Description

Acusphere, Inc. operates as a specialty pharmaceutical company that develops and commercializes cardiovascular drugs. It offers Imagify (perflubutane polymer microspheres), a cardiovascular drug that evaluates myocardial perfusion and detects coronary artery disease. It provides Imagify as an injectable suspension. The company was formerly known as Polymers For Medicine, Inc. and changed its name to Acusphere, Inc. in March 2004. Acusphere, Inc. was founded in 1993 and is based in Watertown, Massachusetts.

ACUS Financial Timeline

Browse a chronological timeline of Acusphere, Inc. corporate events including earnings releases, dividend announcements, and stock splits.

No results found.

ACUS Stock Performance

Access detailed ACUS performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run